Spain: A new observational study published in the American Journal of Emergency Medicine suggests that lung ultrasound may ...

Please provide your email address to receive an email when new articles are posted on . There was a 75.3% rise in bronchiolitis admissions in 2022 to 2023 compared with the median before COVID-19.

Bronchiolitis often affects infants under 2 and is usually caused by the respiratory syncytial virus (RSV). Bronchitis can happen at any age and involves inflammation due to viral infections like ...

The growing role of pediatric intensive care units (PICUs) for managing bronchiolitis in infants and young toddlers over the last decade was associated with increased use of noninvasive respiratory ...

This new research sheds light on the importance of follow-up meetings for young patients discharged from emergency departments (EDs). These new findings and more resulted from a recent retrospective ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

The mainstays of treatment are ensuring adequate rest, hydration, and oxygenation. A humidifier can be used to help loosen sticky mucus. The decision to admit a child to the hospital is made on the ...

A new study at Intermountain Primary Children's Hospital in Salt Lake City and led by faculty at University of Utah Health has found that follow-up appointments for hospitalized children treated for ...

Although inhaled epinephrine (adrenaline) has been found to reduce the need for hospitalization when given to patients with bronchiolitis in the emergency department, it is not clear whether ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first ...